Brief: Glaxosmithkline Pharmaceuticals Ltd Says Juby Chandy Resigns As Whole-Time Director And CFO
16/03/2026 12:29
March 16 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd GLAX.NS: GLAXOSMITHKLINE PHARMACEUTICALS LTD - JUBY CHANDY RESIGNS AS WHOLE-TIME DIRECTOR AND CFO Source text: ID:nBSE84bnN1 Further company coverage: GLAX.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees